|
 |
saquinavir mesylateThis page contains recent news articles, when available, and an overview of saquinavir mesylate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: saquinavir mesylate (when available) Saquinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Saquinavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. HIV-1 with advanced immunodeficiency together with antiretroviral nucleoside analogues Mechanism Of Action: Saquinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. News Articles on Saquinavir Conflictul alimente – medicamente - Jan 4, 2010 ...antiviralele (Saquinavir mesylate), antiaritmicele cardiace (Cardarone), antialgicele (cpodeina), antibioticele (aritromicina, claritromicina). ... Jurnalul Naţional New Study Results Find That Patients Treated With Boosted INVIRASE, A... - Jul 25, 2005 INVIRASE(R) (saquinavir mesylate) capsules and FORTOVASE(R) (saquinavir) soft gelatin capsules are not bioequivalent and cannot be used interchangeably. ... $4.95 - PR Newswire - ECNext Press Release: Interim Analysis of New Study Suggests Boosted … - Nov 13, 2006 Roche's protease inhibitor Invirase (saquinavir mesylate ... fewer patients treated with Invirase developed elevated triglyceride ... lead investigator on ... Pay-Per-View - PR Newswire - HighBeam Research International Approvals: Glumetza, 500-mg Invirase, Proxinium - Jun 6, 2005 Saquinavir mesylate is indicated for use in combination with ritonavir (100-mg twice daily) and other antiretroviral agents in the treatment of HIV ... Medscape Pharmacokinetics and Safety of Saquinavir/Ritonavir and Omeprazole in... - Feb 5, 2007 Saquinavir mesylate summary of product Characteristics. Roche Pharmaceuticals, Roche Laboratories, Nutley, NJ, USA, November (2005). Ko, JW, Sukhova, N., ... Nature.com Rifampin Plus Ritonavir-Boosted Saquinavir Therapy Linked to High... - Feb 10, 2005 Saquinavir mesylate and saquinavir are indicated for use in combination with other ... Saquinavir mesylate must be administered in combination with ... Medscape Press Release: European Approval for Roche's New Invirase 500 mg … - May 27, 2005 Roche announced today the European marketing approval for its new 500 mg formulation of Invirase (saquinavir mesylate), an effective and well tolerated ... Pay-Per-View - PR Newswire Europe - HighBeam Research International Approvals: Invirase and Remicade - May 15, 2006 May 15, 2006 — Health Canada has approved a 500-mg tablet formulation of saquinavir mesylate that significantly reduces the daily pill count for patients ... Medscape Press Release: Roche to Focus Resources on Availability of INVIRASE(R... - Feb 6, 2006 Research Initiative/Treatment Action!; March 1, 2000 ; 700+ words ... ... hard-gel, saquinavir mesylate or Invirase) for use in combination with nucleoside ... Pay-Per-View - PR Newswire - HighBeam Research Reyataz Oral : Uses, Side Effects, Interactions, Pictures, Warnings &... - Sep 30, 2008 Invirase (saquinavir mesylate) US prescribing information. Roche Laboratories, Inc. July, 2007. 10.Nor-QD (norethindrone) US prescribing information. ... WebMD Press Release: Roche to Voluntarily Withdraw Anti-HIV Medication … - May 18, 2005 PR Newswire; November 10, 1997 ; 700+ words ... ... protease inhibitor, INVIRASE(R) (saquinavir mesylate). FORTOVASE is indicated for the ... reflects the ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Study Indicates Boosted Invirase 500 Patients … - Nov 13, 2006 Adults published today recommend boosted Invirase(R) (saquinavir mesylate ... efficacy and tolerability of boosted Invirase together with the convenience . ... Pay-Per-View - PR Newswire Europe - HighBeam Research HIV/AIDS Therapy; Study shows effectiveness of protease inhibitor in ... - Aug 24, 2005 INVIRASE (saquinavir mesylate) capsules and FORTOVASE (saquinavir) soft gelatin capsules are not bioequivalent and cannot be used interchangeably. ... Pay-Per-View - Vaccine Weekly - Factiva, from Dow Jones Reyataz Oral : Uses, Side Effects, Interactions, Pictures, Warnings &... - Sep 30, 2008 12.Fortovase (saquinavir) US prescribing information. Roche Laboratories, Inc. December, 2004. 13.Invirase (saquinavir mesylate) US prescribing information. ... WebMD Levitra Oral : Uses, Side Effects, Interactions, Pictures, Warnings &... - Oct 24, 2006 6.Fortovase (saquinavir) US prescribing information. Roche Laboratories, Inc. December, 2004. 7.Invirase (saquinavir mesylate) US prescribing information. ... WebMD Federal Register 2008 - 73 FR 51829 Publication of Guidances for … - Sep 5, 2008 ...(47) Paliperidone (48) Paricalcitol (49) Phenytoin (50) Pimozide (51) Posaconazole (52) Quinine Sulfate (53) Saquinavir Mesylate (multiple dosage forms) ... Pay-Per-View - Federal Register 2008 - Loislaw Final Gemini Study Results Confirm Boosted Invirase Was as Effective... - Oct 25, 2007 Madrid, demonstrated that treatment-naive HIV patients treated with the protease inhibitor Invirase([R]) 500mg tablets (saquinavir mesylate), ... Free with registration - Business Wire - AccessMyLibrary.com New Data Suggest Boosted Invirase® Has Similar Efficacy to Boosted … - Jul 23, 2007 ...head-to-head trial suggests that HIV patients treated with the protease inhibitor Invirase® 500 (saquinavir mesylate boosted with ritonavir) achieved ... webwire.com Roche to Focus Resources on Availability of Invirase, Now Preferred … - Feb 6, 2006 Invirase® (saquinavir mesylate) capsules and Fortovase® (saquinavir) soft gelatin capsules are not bioequivalent and cannot be used interchangeably. ... DG News New Data Suggest Boosted Invirase(R) has Similar Efficacy to Boosted ... - Jul 20, 2007 ...head-to-head trial suggests that HIV patients treated with the protease inhibitor Invirase(R) 500 (saquinavir mesylate boosted with ritonavir) achieved ... Free with registration - PR Newswire - AccessMyLibrary.com Interim Analysis of New Study Suggests Boosted INVIRASE(R) May … - Nov 13, 2006 ...mg/r (saquinavir mesylate) has the potential to achieve comparable levels of viral suppression to the most commonly used PI, lopinavir/r (Kaletra(R)), ... Free with registration - PR Newswire - AccessMyLibrary.com Roche's Invirase non-inferior to Kaletra. - Nov 5, 2007 Spain, demonstrated that treatment-naive HIV patients treated with Swiss drug major Roche's protease inhibitor Invirase (saquinavir mesylate), ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Patients treated with boosted Invirase, a potent anti-HIV treatment,... - Jul 28, 2005 Starting treatment of HIV infection with Roche's protease inhibitor Invirase® (saquinavir mesylate) boosted with a small dose of ritonavir is not associated ... Medical News Today - Medical News Today (press release) Fortovase.(Drug overview) - Jan 22, 2007 The active ingredient in Invirase is saquinavir mesylate, and although it's similar to the active ingredient in Fortovase, the two drugs are not ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Good Long-Term Efficacy and Safety With Once-Daily Ritonavir-Boosted ... - Aug 18, 2006 ...[Presentation title: Long-term Efficacy and Safety of Once-Daily Ritonavir-Boosted Saquinavir Mesylate (SQV/r) Plus 2 NRTIs. Abstract WEPE0110] DG News Europe approves new Invirase 500 mg tablet for the treatment of HIV - May 27, 2005 Roche announced today the European marketing approval for its new 500 mg formulation of Invirase (saquinavir mesylate), an effective and well tolerated ... Medical News Today - Medical News Today (press release) Patients treated with boosted Invirase, a potent anti-HIV treatment,... - Jul 30, 2005 Starting treatment of HIV infection with Roche's protease inhibitor Invirase® (saquinavir mesylate) boosted with a small dose of ritonavir is not associated ... i-newswire.com Hydroxyurea (Systemic).(Drug overview) - May 1, 2006 Viramune) or Ritonavir (eg, Norvir) or Saquinavir (eg, Fortovase) or Saquinavir mesylate (eg, Invirase) or Stavudine (eg D4T, Zerit) or Zalcitabine (eg, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Europe approves new Invirase 500 mg tablet for the treatment of HIV - May 29, 2005 Roche announced the European marketing approval for its new 500 mg formulation of Invirase (saquinavir mesylate), an effective and well tolerated protease ... Medical News Today - Medical News Today (press release) Roche Women Honored as 2006 TWIN Awardees. - Apr 28, 2006 She led the FDA filings for the early AIDS drugs HIVID(R) (zalcitabine) and Invirase(R) (saquinavir mesylate), which positively affected the lives of ... Free with registration - PR Newswire - AccessMyLibrary.com Roche to Pull HIV/AIDS Drug Due to Dwindling Demand - May 18, 2005 A new formulation of Invirase (saquinavir mesylate) has become the preferred formulation of saquinavir, Roche said. Invirase will remain on the market in ... Daily News Central New European HIV Treatment Guidelines Recommend Boosted Invirase( … - Nov 20, 2005 New European Guidelines for the Clinical Management and Treatment of HIV Infected Adults published today recommend boosted Invirase(R) (saquinavir mesylate) ... Medical News Today - Medical News Today (press release) Press Release: FUZEON Combined With New Investigational HIV Drug … - Oct 5, 2006 Invirase(R) (saquinavir mesylate) has demonstrated the best HIV RNA response yet seen in a large group of HIV-infected patients given highly active ... Pay-Per-View - PR Newswire Europe - HighBeam Research Roche's Invirase 500mg gets US approval.(Brief Article) - Jan 3, 2005 ...(saquinavir mesylate), designed for use in combination with a small dose of ritonavir and other anti-HIV drugs for the treatment of HIV infection. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Invirase lowers HIV levels with better lipid profile. - Nov 20, 2006 Swiss drug major Roche says that data from a study of its protease inhibitor Invirase (saquinavir mesylate) indicates that it suppresses HIV viral load to a ... $9.94 - Pharma Marketletter - Alacra Store Roche discontinues Fortovase.(Noted) - Jun 1, 2005 ...the availability of a higher dose (500 mg) formulation of Invirase (saquinavir mesylate). Fortovase will be discontinued during the first quarter 2006. Free with registration - Pharmaceutical Processing - AccessMyLibrary.com Hydroxyurea (Systemic). - Oct 27, 2005 Viramune) or Ritonavir (eg, Norvir) or Saquinavir (eg, Fortovase) or Saquinavir mesylate (eg, Invirase) or Stavudine (eg D4T, Zerit) or Zalcitabine (eg, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Italy OKs nine drugs for reimbursement.(Brief Article) - Oct 24, 2005 They include Roche's HIV/AIDS drug Invirase (saquinavir mesylate) and five generic equivalents of the beta blocker carvedilol, Pfizer's depression and ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Valium Inventor Inducted into National Inventors Hall of Fame; -... - Feb 10, 2005 ...led to other innovative drugs such as Rocephin(R) (oseltamivir phosphate), Invirase(R) (saquinavir mesylate) and Pegasys(R) (peginterferon alfa-2a)." ... $4.95 - PR Newswire - ECNext HIV/AIDS Therapy; Invirase receives FDA marketing approval - Jan 17, 2005 Invirase (saquinavir mesylate) is an HIV protease inhibitor approved for use in combination with a small dose of ritonavir ('boosting') and other antiHIV ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Roche; Invirase receives FDA marketing approval - Jan 19, 2005 Invirase (saquinavir mesylate) is an HIV protease inhibitor approved for use in combination with a small dose of ritonavir ('boosting') and other antiHIV ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones HIV/AIDS Therapy; US FDA approves 500 mg HIV protease inhibitor to … - Jan 23, 2005 ...(saquinavir mesylate), designed for use in combination with a small dose of ritonavir and other anti-HIV drugs for the treatment of HIV infection. ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Europe advocates Invirase use for HIV.(Brief Article) - Nov 28, 2005 New European guidelines for the clinical management and treatment of HIV-infected adults recommends boosted Invirase (saquinavir mesylate), ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Press Release: New European HIV Treatment Guidelines Recommend … - Nov 18, 2005 New European Guidelines for the Clinical Management and Treatment of HIV Infected Adults published today recommend boosted Invirase(R) (saquinavir mesylate) ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Patients Treated With Boosted Invirase, a Potent Anti... - Jul 25, 2005 Starting treatment of HIV infection with Roche's protease inhibitor Invirase(R) (saquinavir mesylate) boosted with a small dose of ritonavir is not ... Pay-Per-View - PR Newswire Europe - HighBeam Research Factiva Search - Jul 25, 2005 Patients starting HIV treatment with Roche's protease inhibitor Invirase (saquinavir mesylate) boosted with a small ... ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Roche's new Invirase version OKd in EU.(pharmaceutial industry)(Brief... - Jun 6, 2005 Swiss drug major Roche has obtained European marketing approval for its new 500mg formulation of Invirase (saquinavir mesylate), a protease inhibitor for ... $4.95 - Pharma Marketletter - ECNext New formulations. - Jan 24, 2005 A new 500-mg film-coated tablet formulation of Invirase (saquinavir mesylate) has been approved for Roche Pharmaceuticals, Nutley, N.J., (800) 526-6367. ... $9.94 - Drug Topics - Alacra Store … HIV-Behandlungsrichtlinien empfehlen geboostetes Saquinavir als … - Nov 29, 2005 Die neuen europäischen Richtlinien zur klinischen Verwaltung und Behandlung HIV-infizierter Erwachsener empfehlen Geboostetes Saquinavir Mesylate für ... journalmed.de News Invest :: Les Services en Marketing - Jul 25, 2005 Entamer un traitement de l'infection au VIH avec l'inhibiteur de protéaseInvirase(R) (saquinavir mesylate), renforcé d'une petite dose de ritonavirn'est pas ... newsinvest.fr News Invest :: Les Services en Marketing - Nov 18, 2005 ...l'Inviraserenforcé(R) (saquinavir mesylate) comme inhibiteur de protéase de premierchoix pour les patients entamant une thérapie antirétrovirale[1]. ... newsinvest.fr Aprobación europea de la nueva tableta Invirase 500 mg - Jun 7, 2005 El Laboratorio Roche anunció recientemente la aprobación de comercialización en Europa de su nueva formulación de 500 mg de Invirase (saquinavir mesylate), ... universia.net.co Neue europäische HIV-Behandlungsrichtlinien empfehlen geboostetes … - Nov 18, 2005 Geboostetes Invirase(R) (Saquinavir Mesylate) für Patienten, die ihre antiretrovirale Behandlung beginnen, als Protease-Inhibitor der ersten Wahl[1]. ... presseportal.de Roche sắp ngừng bán thuốc Fortovase trị HIV - May 20, 2005 Roche cho biết loại thuốc Invirase (saquinavir mesylate) công thức má»›i dạng 500 mg có Æ°u Ä‘iểm vượt trá»™i so vá»›i thuốc Fortovase (saquinavir) vì viên nhá»? hÆ¡n, ... VietNamNet Brand Names/Synonyms: saquinavir mesylate is also known by the following brand names and/or synonymsFortovase; Invirase; ROC; SAQUINAVIR; SQV; Saquinavir; Saquinavir Mesylate; Saquinavir [Usan] Drug Category: saquinavir mesylate is categorized under the following by the FDA: Anti-HIV Agents; Anti-HIV Agents; ATC:J05AE01 Dosage Forms: INVIRASE (saquinavir mesylate) capsules and FORTOVASE (saquinavir) soft gelatin capsules Absorption: Absolute bioavailability of saquinavir administered as INVIRASE averaged 4% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N-[1-benzyl-2-hydroxy-3-[3-(tert-butylcarbamoyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinolin-2-yl]-propyl]-2-quinolin-2-ylcarbonylamino-butanediamide |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |